Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 1.479G;0.225G;0.188G | 2 | SUTAB | SODIUM SULFATE;MAGNESIUM SULFATE;POTASSIUM |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2020-11-10 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2022-01-28 | STANDARD |
Submissions Property Types
CDER Filings
BRAINTREE LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 213135
[companyName] => BRAINTREE LABS
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/213135s000lbl.pdf#page=14"]
[products] => [{"drugName":"SUTAB (COPACKAGED)","activeIngredients":"MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE","strength":"0.225GM;0.188GM;1.479GM","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"11\/10\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213135s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"11\/10\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213135s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/213135Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2020-11-10
)
)